BPC-157: What the Preclinical Research Actually Shows

Research Use Only: The information below is a summary of published scientific literature intended for laboratory and research audiences. Nothing here is medical advice, and none of the compounds discussed are approved for human or veterinary use.

What is BPC-157?

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide, meaning a chain of 15 amino acids, that corresponds to a partial sequence of a protein originally identified in human gastric juice. It was first characterised by the Croatian research group led by Predrag Sikiric, whose team has published extensively on the peptide’s cytoprotective and organoprotective properties in animal models.

Within the research-peptide space, BPC-157 is one of the most frequently studied and searched compounds, largely because of the volume of preclinical literature surrounding tissue-repair pathways.

Where BPC-157 sits in the research literature

The majority of the BPC-157 evidence base comes from in vitro (cell) and in vivo (animal) studies. Reviewers consistently note that human clinical data remain extremely limited. Understanding this distinction is essential when interpreting any claim about the peptide.

Reported areas of preclinical interest

• Musculoskeletal tissue models: the largest body of BPC-157 research examines tendon, ligament, muscle and bone repair pathways in animals.
• Gastrointestinal models: consistent with its origin in gastric juice, several studies explore effects on gut-lining integrity.
• Cytoprotective and anti-inflammatory signalling: work on cell-survival and angiogenesis-related pathways such as VEGFR2.

BPC-157 chemistry at a glance

BPC-157 is a stable gastric pentadecapeptide with the amino-acid sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is typically supplied as a lyophilised acetate salt for laboratory reconstitution. These are physicochemical facts relevant to handling and analysis, not indications of any use in humans.

Why the “research use only” label matters

BPC-157 has not been approved by the FDA, EMA, or any comparable regulatory authority for human use, and no large-scale human clinical trials have established safety or efficacy. In 2022 the World Anti-Doping Agency (WADA) added BPC-157 to its prohibited list, which is relevant context for anyone working in sports-science research settings.

For these reasons, compounds like BPC-157 are supplied strictly for laboratory and scientific research, and are not intended for human or veterinary consumption.

BPC-157 in blended research compounds

In the research market, BPC-157 is sometimes studied alongside other peptides investigated for tissue-support pathways, such as TB-500 and the copper peptide GHK-Cu. Our GLOW research blend (GHK-Cu, TB-500, BPC-157) is one example of a multi-peptide formulation intended purely for laboratory research.

Handling and storage considerations for researchers

Peptides such as BPC-157 are typically supplied as a lyophilised (freeze-dried) powder. General laboratory best practice is to store lyophilised peptides cool and dry, protected from light, and to keep reconstituted material refrigerated and used within the timeframe indicated by stability data. Always follow your own institution’s handling protocols and the documentation supplied with the product.

Frequently asked questions

Is BPC-157 approved for human use?

No. BPC-157 is classified as a research compound only. It is not approved by the FDA, EMA, or other regulators, and it is not intended for human or veterinary use.

What kind of studies have been done on BPC-157?

The evidence base is dominated by cell-culture and animal studies. Published human clinical trial data are very limited, so conclusions drawn from animal models should not be extrapolated to people.

Why is BPC-157 on the WADA prohibited list?

WADA added BPC-157 to its prohibited substances list in 2022. Researchers operating in sport-adjacent contexts should be aware of this status.

Is BPC-157 legal to buy for research in the EU?

In the EU, research peptides are generally handled as chemical reagents rather than medicinal products, provided they are sold and labelled strictly for laboratory research and without any human-use or therapeutic presentation. Buyers are responsible for compliance with local rules.

How should BPC-157 be stored in a lab setting?

Lyophilised peptide is generally kept cool, dry and away from light, with reconstituted solution refrigerated. Follow the stability guidance and safety documentation provided with each batch.

Key takeaways

BPC-157 is one of the most studied research peptides, with a preclinical literature focused on tissue-repair and cytoprotective pathways. That said, human evidence is limited, the compound is unapproved for human use, and it is prohibited in competitive sport. It should be handled exclusively as a research material. For laboratories exploring multi-peptide formulations, the GLOW blend combines BPC-157 with TB-500 and GHK-Cu for research purposes only.

References

1. Chang C-H, et al. Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts. PMC6271067.
2. Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing. PMC12446177.
3. Emerging Use of BPC-157 in Orthopaedic Sports Medicine. PMC12313605.
4. BPC-157 overview. Wikipedia.

Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.